Genscript Biotech Corporation Stocks 26 percent Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
| GNNSF Stock | USD 1.25 0.01 0.79% |
Roughly 61% of Genscript Biotech's investor base is looking to short. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
Genscript |
Genscript Biotech Corporation Stocks 26 percent Dive Might Signal An Opportunity But It Requires Some Scrutiny Simply Wall St
Read at news.google.com
 |
Genscript Biotech Fundamental Analysis
We analyze Genscript Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genscript Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genscript Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Genscript Biotech is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Genscript Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genscript Biotech pink sheet to make a market-neutral strategy. Peer analysis of Genscript Biotech could also be used in its relative valuation, which is a method of valuing Genscript Biotech by comparing valuation metrics with similar companies.
Peers
Genscript Biotech Related Equities
| ICCC | ImmuCell | 6.03 | ||||
| TLPPF | Telix Pharmaceuticals | 5.40 | ||||
| MRUS | Merus BV | 3.33 | ||||
| KROS | Keros Therapeutics | 2.17 | ||||
| IVBXF | Innovent Biologics | 0.62 | ||||
| NUVL | Nuvalent | 0.05 | ||||
| NUVB | Nuvation Bio | 0.76 | ||||
| INBX | Inhibrx | 0.88 | ||||
| NXTC | NextCure | 0.92 | ||||
| ZNTL | Zentalis Pharmaceuticals | 1.28 | ||||
| LCTX | Lineage Cell | 1.92 | ||||
| KRON | Kronos Bio | 2.00 | ||||
| CNTB | Connect Biopharma | 2.61 | ||||
| OVID | Ovid Therapeutics | 2.83 | ||||
| CVKD | Cadrenal Therapeutics, | 3.45 | ||||
| CRNX | Crinetics Pharmaceuticals | 3.52 | ||||
| ONTTF | Oxford Nanopore | 3.92 | ||||
| LYEL | Lyell Immunopharma | 11.84 |
Complementary Tools for Genscript Pink Sheet analysis
When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |